BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $3,972,000 | +5.9% | 63,299 | +2.1% | 0.02% | 0.0% |
Q2 2017 | $3,752,000 | +15.2% | 61,970 | -1.3% | 0.02% | +9.1% |
Q1 2017 | $3,258,000 | +25.3% | 62,815 | +7.1% | 0.02% | +15.8% |
Q4 2016 | $2,600,000 | -3.2% | 58,636 | +3.9% | 0.02% | -9.5% |
Q3 2016 | $2,687,000 | +7.5% | 56,460 | +2.2% | 0.02% | 0.0% |
Q2 2016 | $2,499,000 | +7.4% | 55,252 | -2.4% | 0.02% | 0.0% |
Q1 2016 | $2,326,000 | -9.5% | 56,631 | -16.0% | 0.02% | -12.5% |
Q4 2015 | $2,571,000 | +14.8% | 67,383 | -1.1% | 0.02% | 0.0% |
Q3 2015 | $2,239,000 | -45.9% | 68,158 | +15.2% | 0.02% | -41.5% |
Q2 2015 | $4,136,000 | +5.4% | 59,143 | +3.2% | 0.04% | 0.0% |
Q1 2015 | $3,924,000 | -0.4% | 57,288 | +6.6% | 0.04% | -6.8% |
Q4 2014 | $3,939,000 | +19.1% | 53,748 | +16.6% | 0.04% | +10.0% |
Q3 2014 | $3,308,000 | +16.0% | 46,096 | +16.9% | 0.04% | +14.3% |
Q2 2014 | $2,852,000 | +8.6% | 39,444 | +10.5% | 0.04% | -2.8% |
Q1 2014 | $2,627,000 | +20.7% | 35,705 | +14.0% | 0.04% | +12.5% |
Q4 2013 | $2,177,000 | +11.8% | 31,307 | +5.7% | 0.03% | 0.0% |
Q3 2013 | $1,947,000 | -4.5% | 29,632 | +0.7% | 0.03% | -11.1% |
Q2 2013 | $2,038,000 | – | 29,417 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |